When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

3. Blood test to detect colon cancer could move a step closer to ...

   www.aol.com/news/blood-test-detect-colon-cancer...

   About 90% of the study participants without advanced colorectal cancer or precancerous lesions tested negative on the blood test, compared with about 10% who had a false positive test result. Many ...

4. Cancer screening - Wikipedia

   en.wikipedia.org/wiki/Cancer_screening

   Cancer screening. A person preparing for breast cancer screening by mammography. Purpose. detection of cancer prior to onset of symptoms (via several tests/imaging) The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. [ 1 ][ 2 ...

5. FDA approves new blood test for colorectal cancer screening

   www.aol.com/fda-approves-blood-test-colorectal...

   A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood ...

6. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1][2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates. [2] Screening precedes a diagnosis and subsequent treatment.

7. Cancer biomarker - Wikipedia

   en.wikipedia.org/wiki/Cancer_biomarker

   A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, [1] epigenetic, [2] proteomic, [3] glycomic, [4] and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood ...